Today: 7 February 2026
Subscribe

SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

Shares of Sarepta Therapeutics (NASDAQ: SRPT) head into Tuesday’s session trying to build on a rare rally, as investors digest a positive safety update for its experimental RNA therapy SRP‑1003 and weigh it against fresh FDA warnings and trial setbacks tied to its gene therapy Elevidys. SRPT stock today at a glance As of Monday’s close (November 24, 2025), here’s where SRPT stands: In other words, Monday’s bounce was meaningful, but comes after a brutal collapse from triple‑digit levels earlier in 2025. New SRP‑1003 data: a rare bright spot for SRPT stock On Monday, Sarepta released a progress update for
25 November 2025
··
RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

Rumble Inc. (NASDAQ: RUM) heads into Tuesday’s session on the back of one of its strongest two-day moves of 2025, fueled by fresh commitments from crypto giant Tether and a transformational AI infrastructure deal with Germany’s Northern Data. As of Monday, November 24, RUM closed at $6.51, up about 14.4% on the day, after trading between $5.92 and $6.57 on unusually heavy volume of roughly 7.2 million shares, well above recent averages. FinancialContent That follows a 7% gain on Friday, lifting the stock more than 22% over the last two sessions and putting it back near the upper end of
25 November 2025
···
NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

New Era Energy & Digital, Inc. (NASDAQ: NUAI) heads into Tuesday’s session on the back of a sharp rally and a major expansion update for its flagship Texas AI data center project. As of Monday’s close on November 24, NUAI finished at $4.40, up about 15.8% on the day, with roughly 8.6 million shares traded on the Nasdaq. StockAnalysis The stock remains deeply volatile and, despite the latest bounce, is still down more than 60% over the past 12 months. StockAnalysis This move followed fresh news that the company’s joint venture has locked in more land for its Texas AI
25 November 2025
···
Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s Corporation (NYSE: KSS) heads into a high‑stakes trading day on Tuesday, November 25, 2025, with a fresh CEO, an earnings report due, and the holiday shopping season ramping up—all against a backdrop of heavy short interest and lingering doubts about the department‑store model. As of early Tuesday, KSS is trading around $15.70 per share, giving Kohl’s a market value of roughly $1.8 billion and leaving the stock in the lower half of its 52‑week range of about $6.04 to $21.39. GuruFocus+1 Key Takeaways for KSS Stock on November 25, 2025 KSS Stock Price Today: Volatile but Off the Lows
25 November 2025
·
Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Technologies stock is back under the spotlight today as investors brace for the company’s third‑quarter fiscal 2026 earnings report after the closing bell. Dell shares finished Monday, November 24, at $127.22, up about 3.8% on the day, but still roughly 24% below their early‑November high near $168. StockAnalysis+1 Over the past month, the stock has dropped almost 20%, even after Monday’s rebound, while it remains up around 10% year‑to‑date and down about 12% over the last 12 months. MarketBeat+1 That combination of strong year‑to‑date gains, a sharp recent sell‑off, and a big AI narrative makes Dell one of the
25 November 2025
···
PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

As traders log in on Tuesday, November 25, 2025, Plus Therapeutics (NASDAQ:PSTV) is back on the radar thanks to a cluster of late‑November catalysts: an FDA Type B meeting for lead radiotherapeutic REYOBIQ™, a fresh 180‑day Nasdaq bid‑price extension, and a national coverage agreement with Humana for its CNSide® cancer diagnostic. As of the latest completed trading session on Monday, November 24, PSTV last changed hands at $0.5752, up roughly 8% on the day, after trading between $0.50 and $0.59 on volume of about 8.4 million shares. Even after that bounce, the stock still sits well below its 52‑week high
25 November 2025
·
VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

Viking Therapeutics (NASDAQ: VKTX) heads into the Tuesday, November 25, 2025 session trading in the mid‑$30s, still digesting last week’s major milestone: the company has finished enrolling patients in its pivotal Phase 3 obesity trial VANQUISH‑1 ahead of schedule and above its original target. Viking Therapeutics InvestorRoom As of yesterday’s close (Monday, November 24), VKTX changed hands at $34.65, implying a market capitalization of roughly $3.9 billion. Stock Titan Shares sit well below their 52‑week high of $56.25, but far above the 52‑week low of $18.92, underscoring how volatile the weight‑loss drug trade has become. Investing.com+1 With Phase 3 trials
25 November 2025
··
Johnson & Johnson (JNJ) Stock on November 25, 2025: Ex‑Dividend Day, Options Surge and a $3 Billion Cancer Bet

Johnson & Johnson (JNJ) Stock on November 25, 2025: Ex‑Dividend Day, Options Surge and a $3 Billion Cancer Bet

Date: November 25, 2025 Johnson & Johnson (NYSE: JNJ) heads into Tuesday’s session at or near record highs, riding a wave of bullish options activity, a key ex‑dividend date today and a string of growth-focused pipeline moves in cancer and neuroscience. As of the latest completed trading session on Monday, November 24, JNJ was trading around $206 per share, close to its 12‑month high just under $207, with a 12‑month low near $141, a price/earnings ratio around 20 and a dividend yield in the ballpark of 2.5%–2.6%.MarketBeat+1 The stock is up more than 7% since the first trading day of
25 November 2025
··
Coca-Cola (KO) Stock on November 25, 2025: Price, Dividend and Outlook After Q3 Earnings

Coca-Cola (KO) Stock on November 25, 2025: Price, Dividend and Outlook After Q3 Earnings

As markets head into the Tuesday, November 25, 2025 session, Coca-Cola Company (The) stock (NYSE: KO) is trading in classic “steady blue‑chip” fashion: modest price moves, strong dividend support, and quietly improving fundamentals. As of the close on Monday, November 24, KO finished at $72.59, down about 0.5% on the day but still up roughly 13–14% over the last 12 months and trading well above both its 50‑day and 200‑day moving averages.StockAnalysis Over the past year, the stock has moved in a range of roughly $60–$74, leaving it nearer the upper half of that band as investors position for year‑end.MarketBeat+1
25 November 2025
DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

Diginex Limited (NASDAQ: DGNX) has become one of 2025’s wildest small-cap stories. The ESG and sustainability RegTech firm has seen its DGNX stock rocket more than 1,100% year-to-date, powered by index inclusion, aggressive M&A plans and a wave of interest in compliance-focused AI.Simply Wall St+1 Now, heading into Tuesday, November 25, 2025, DGNX is back in the spotlight after the company signed a non‑binding memorandum of understanding (MOU) to acquire The Remedy Project, a specialist in human-rights risk and worker-centered remediation for global supply chains.ir.diginex.com+2Nasdaq+2 Below is a detailed look at where DGNX stock stands today, what’s driving the latest
25 November 2025
·
Palo Alto Networks (PANW) Stock Today – November 25, 2025: Earnings ‘Beat and Raise’, AI Deals and What to Watch Next

Palo Alto Networks (PANW) Stock Today – November 25, 2025: Earnings ‘Beat and Raise’, AI Deals and What to Watch Next

Palo Alto Networks, Inc. (NASDAQ: PANW) heads into the November 25, 2025 trading day as one of the most closely watched cybersecurity stocks on Wall Street, with fresh headlines about its earnings, big AI‑focused acquisitions and a sharp pullback in the share price all competing for investor attention. As of the last completed U.S. trading session on Monday, November 24, 2025, Palo Alto Networks stock closed at $183.89, up about 0.5% on the day, after trading between roughly $182 and $187 on volume of just over 11 million shares.StockAnalysis That closing level leaves PANW well below its late‑October high near
25 November 2025
···
Lam Research (LRCX) Stock Jumps Over 5% as AI Chip Rally Lifts Semiconductors – Price, News and Outlook for 25 November 2025

Lam Research (LRCX) Stock Jumps Over 5% as AI Chip Rally Lifts Semiconductors – Price, News and Outlook for 25 November 2025

Lam Research Corporation (NASDAQ: LRCX) is back in the spotlight after a powerful tech-led rally pushed the stock more than 5% higher in the latest U.S. trading session, adding to an already stellar 2025 run. As of the morning of 25 November 2025, the freshest data investors can see reflects Monday’s close at about $150.38 per share, up roughly 5.4% on the day. barchart.com While Lam hasn’t issued any new company press releases today, several fresh market reports and analyst pieces from the last few days — plus Monday’s sharp move — are shaping the story for LRCX right now.
25 November 2025
·
Visa Stock Today: Holiday Tailwinds, Stablecoin Push and Fresh Analyst Calls (November 25, 2025)

Visa Stock Today: Holiday Tailwinds, Stablecoin Push and Fresh Analyst Calls (November 25, 2025)

Visa Inc. (NYSE: V) heads into Tuesday’s session sitting near all‑time highs, with investors digesting a wave of new headlines around holiday spending, stablecoins and fresh analyst commentary. Visa stock today: price, performance and key metrics As of early trading on November 25, 2025, Visa’s most recent official close was $329.30 on Monday, after trading in a $326.00–$330.73 range. The stock remains well above its 52‑week low of $299.00, but still about 12–13% below its record high of $375.51 set in June.StockAnalysis+1 Pre‑market data from Investing.com shows Visa changing hands around $328–$329, down only a fraction from Monday’s close, implying
25 November 2025
Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

As investors head into the Tuesday, November 25 session, Pfizer Inc. (NYSE: PFE) remains one of Wall Street’s most closely watched healthcare names. After a brutal comedown from its pandemic-era highs, the drugmaker is trying to convince the market that a new growth story is taking shape around obesity drugs, oncology and a large – and growing – dividend. As of late Monday trading, Pfizer shares were changing hands around $25 per share, giving the company a market value of roughly $143 billion and placing the stock in the middle of its 52‑week range between $20.92 and $27.69.StockAnalysis+1 At that
25 November 2025
Mastercard (MA) Stock Today, November 25, 2025: Price, Fresh News and What It Means for Investors

Mastercard (MA) Stock Today, November 25, 2025: Price, Fresh News and What It Means for Investors

Mastercard (NYSE: MA) stock heads into November 25, 2025 trading after a modest pullback, fresh card launches in Bangladesh, and continued momentum in AI, crypto and digital payments – all under the shadow of a new $38 billion U.S. swipe-fee settlement. Key takeaways Mastercard share price snapshot for November 25, 2025 Heading into Tuesday, November 25, 2025, Mastercard Incorporated (NYSE: MA) is trading close to the middle of its recent range after a modest pullback. Over the past 12 months, MA has traded between $465.59 and $601.77, reflecting its role as a high‑quality but not hyper‑volatile large‑cap. StockAnalysis+1 On fundamentals,
25 November 2025
Oklo (OKLO) Stock Today, 25 November 2025: Price, Citi Upgrade, $13 Billion Wipeout and What’s Next

Oklo (OKLO) Stock Today, 25 November 2025: Price, Citi Upgrade, $13 Billion Wipeout and What’s Next

Oklo Inc. (NYSE: OKLO) heads into Tuesday, 25 November 2025, as one of the most volatile — and most debated — names in the nuclear and AI-energy trade. The stock is hovering around the high‑$80s after rocketing to nearly $200 in October and then shedding more than half its value in a matter of weeks. CryptoRank+1 Fresh headlines over the last 24 hours include a Citi price‑target hike, new institutional ownership disclosures, and more analysis of the company’s Siemens Energy deal and regulatory milestones. At the same time, analysts and commentators are openly wrestling with whether Oklo’s valuation can be
25 November 2025
TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had a busy news day on Monday — and the stock still finished sharply lower. Shares of the small-cap biotech closed around $14.29 on November 25, 2025, down roughly 11% on the session, putting the stock well below its recent highs despite a fresh U.S. FDA green light to advance a new depression treatment into Phase 2 trials. TNXP now trades near the lower end of its volatile 52‑week range of $6.76 to $130.00, with a market capitalization of about $168 million. StockAnalysis At the same time, Tonix is transitioning from a pure development-stage
25 November 2025
Ciena Stock News Today, 25 November 2025: CIEN Jumps 9% on AI Networking Demand Ahead of Q4 Earnings

Ciena Stock News Today, 25 November 2025: CIEN Jumps 9% on AI Networking Demand Ahead of Q4 Earnings

Ciena Corporation (NYSE: CIEN) heads into 25 November 2025 riding another powerful surge in its share price, powered by relentless investor enthusiasm for AI-driven networking and a packed pipeline of optical deals around the world. As of the latest completed U.S. trading session (Monday, 24 November 2025), Ciena closed around $194.70, up roughly 9.3% on the day, after gaining $16.50 from the prior close of $178.20. Intraday, the stock traded roughly between $180 and $197, on exceptionally heavy volume of about 14 million shares, far above its typical daily turnover of just under 3 million. Yahoo Finance+1 At this level,
25 November 2025
··
Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Ticker: BIDU • Exchange: Nasdaq • Date: November 25, 2025 BIDU Stock Jumps as Wall Street Turns More Bullish Baidu’s U.S.-listed shares (NASDAQ: BIDU) rallied sharply on Monday, November 25, 2025, as investors digested fresh analyst upgrades and continued to reposition around the Chinese search and AI giant’s high-spend transformation. By the close, BIDU was trading around $119 per share, up roughly 7.5% on the day from Friday’s $110.95 close. Investing The move added billions of dollars to Baidu’s market value, lifting its market capitalization to around $41 billion. StockAnalysis The rally comes just days after Baidu reported a revenue
25 November 2025
·
Caterpillar (CAT) Stock Today, November 25, 2025: Price, News and AI Data Center Tailwinds

Caterpillar (CAT) Stock Today, November 25, 2025: Price, News and AI Data Center Tailwinds

Updated with market data as of the close on Monday, November 24, 2025 CAT stock price today: still near record highs Caterpillar Inc. (NYSE: CAT) continues to trade near all‑time highs after another strong session on Monday. Caterpillar shares are now up roughly 52% year to date, making CAT the top‑performing stock in the Dow Jones Industrial Average in 2025, even beating out Nvidia’s ~40% gain this year. Finviz+1 On Monday, CAT was also one of the main engines behind the broader market rally. According to MarketWatch data, gains in Merck and Caterpillar together added around 100–110 points to the
25 November 2025
·
1 … 1,236 1,237 1,238 1,239 1,240 … 1,631

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop